Counterbalancing patient demands with evidence: Results from a Pan-Canadian randomized clinical trial of brief supportive-expressive group psychotherapy for women with systemic lupus erythematosus

Annals of Behavioral Medicine

Volumn 24, Issue 2, 2002, Pages 88-99

  Dobkin, Patricia L ^a   Da Costa, Deborah ^a   Joseph, Lawrence ^a   Fortin, Paul R ^b   Edworthy, Steven ^c   Barr, Susan ^c   Ensworth, Stephanie ^d   Esdaile, John M ^d   Beaulieu, André ^e   Zummer, Michel ^e   Senécal, Jean Luc ^f   Goulet, Jean Richard ^f   Choquette, Denis ^f   Rich, Eric ^f   Smith, Doug ^g   Cividino, Alfred ^h   Gladman, Dafna ⁱ   St Pierre, Yvan ^a   Clarke, Ann E ^a  

^a MONTREAL GENERAL HOSPITAL   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

^c UNIVERSITY OF CALGARY   (Canada)

^d UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^e UNIVERSITÉ LAVAL   (Canada)

^f NOTRE DAME HOSPITAL   (Canada)

^g UNIVERSITY OF OTTAWA   (Canada)

^h MCMASTER UNIVERSITY   (Canada)

ⁱ UNIVERSITY HEALTH NETWORK   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ADAPTIVE BEHAVIOR; ADULT; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; GROUP THERAPY; HEALTH SERVICE; HOSPITALIZATION; HUMAN; LENGTH OF STAY; MAJOR DEPRESSION; MALE; METHODOLOGY; MIDDLE AGED; PSYCHOLOGICAL ASPECT; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL; SOCIAL SUPPORT; SYSTEMIC LUPUS ERYTHEMATOSUS; UNITED STATES; UTILIZATION REVIEW; CANADA; COPING BEHAVIOR; DISEASE ACTIVITY; DISTRESS SYNDROME; HEALTH CARE COST; HEALTH CARE UTILIZATION; MAJOR CLINICAL STUDY; OUTCOMES RESEARCH; PATIENT REFERRAL; PRODUCTIVITY; PSYCHOLOGIC ASSESSMENT; PSYCHOTHERAPY; SYMPTOMATOLOGY; TREATMENT INDICATION; TREATMENT OUTCOME;

ADAPTATION, PSYCHOLOGICAL; ADULT; DEPRESSIVE DISORDER, MAJOR; FEMALE; HEALTH SERVICES NEEDS AND DEMAND; HOSPITALIZATION; HUMANS; LENGTH OF STAY; LUPUS ERYTHEMATOSUS, SYSTEMIC; MALE; MIDDLE AGED; PSYCHOTHERAPY, GROUP; QUALITY OF LIFE; SOCIAL SUPPORT; UNITED STATES; DEPRESSION, INVOLUTIONAL; HUMAN; MIDDLE AGE; SUPPORT, NON-U.S. GOV'T;

PREDNISONE;

EID: 0035987227     PISSN: 08836612     EISSN: None     Source Type: Journal    
DOI: 10.1207/S15324796ABM2402_05     Document Type: Article

References (58)

1. Self-help groups at the turning point: Emerging egalitarian alliances with the formal health care system?
2. Rethinking medicine: Improving health outcomes with cost-effective psychosocial interventions
3. The cost and effectiveness of an education program for adults who have asthma
4. Reduced risk of hospitalization for lupus patients during a patient counseling intervention
5. A national demographic portrait of mutual aid group participants in Canada
6. Arthritis patient education studies, 1987-1991: A review of the literature
7. Evidence suggesting that health education for self-management in patients with chronic arthritis has sustained health benefits while reducing health care costs
8. Evidence suggesting that a chronic disease self-management program can improve health status while reducing hospitalization
9. The effect of person-centered counseling on the psychological status of persons with systemic lupus erythematosus or rheumatoid arthritis: A randomized, controlled trial
10. Specific psychosocial and behavioral outcomes from the systemic lupus erythematosus self-help course
11. Description of learned response to chronic illness: Depressed versus nondepressed self-help class participants
12. Health outcome improvements in patients with systemic lupus erythematosus using two telephone counseling interventions
13. The effects of patient counseling on coping behavior and health status in lupus patients
14. Effect of psychosocial treatment on survival of patients with metastatic breast cancer
15. Randomized trial of group psychosocial support in metastatic breast cancer: The BEST study
16. Group psychotherapy for recently diagnosed breast cancer patients: A multicenter feasibility study
17. Effect of mental health treatment on medical costs
18. The 1982 revised criteria for the classification of systemic lupus erythematosus
19. The MOS 36-Item Short-Form Health Survey (SF-36). I. Conceptual framework and item selection
20. Validating the SF-36 health survey questionnaire: New outcome measure for primary care
21. Comparison of methods for the scoring and statistical analysis of SF-36 health profile and summary measures: Summary of results from the Medical Outcomes Study
22. Canadian normative data for the SF-36 health survey
23. Reliability and validity of six systems for the clinical assessment of disease activity in SLE
24. The relation between disease activity and expert physician's decision to start major treatment in active systemic lupus erythematosus: A decision aid for development of entry criteria for clinical trials
25. Derivation of the SLEDAI. A disease activity index for lupus patients
26. Do lupus disease activity measures detect clinically important change?
27. The development and initial validation of the SLICC/ACR damage index for SLE
28. The reliability of the SLICC/ACR damage index in patients with SLE
29. A Canadian study of the total medical costs for patients with systemic lupus erythematosus and the predictors of costs
30. A multicenter study of annual health service utilization and costs in rheumatoid arthritis
31. A brief measure of social support: Practical and theoretical implications
32. Adaptation in patients with chronic rheumatoid arthritis: Application of a general model
33. Stress, coping and psychological adjustment of adults with sickle cell disease
34. The impact of daily stress on health and mood: Psychological and social resources as mediators
35. Placing trials in context using Bayesian analysis
36. The case for confidence intervals in controlled clinical trials
37. Bayes factors
38. Group psychotherapy for medical patients
39. Support groups
40. Iron stores and coronary artery disease. A clinical application of a method to incorporate measurement error of the exposure in a logistic regression model
41. Effects of group therapy on women with primary breast cancer
42. Living with lupus: A cross-Canada prospective study
43. Group psychotherapy for breast cancer patients: Geneva experiments
44. The structure and properties of the Sense of Coherence Scale
45. Outcome of Cognitive-Behavioral and Support Group Brief Therapies for depressed, HIV-infected persons
46. Treatment of Depression in MS: Comparative outcomes for individual cognitive-behavior therapy, supportive-expressive group psychotherapy, and sertraline for the treatment of depression in multiple sclerosis
47. 18, Psychotherapy for Inflammatory Bowel Disease: New Prospects
48. Why patients use alternative medicine
49. The use of alternative medical therapies in patients with systemic lupus erythematosus
50. Education and peer discussion group interventions and adjustment to breast cancer